- Home
- PROP vs IBIO Comparison
PROP vs IBIO Comparison
Compare PROP & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROP | IBIO |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.6M | 84.6M |
| IPO Year | 2008 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PROP | IBIO |
|---|---|---|
| Price | $1.66 | $2.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $6.75 | $4.75 |
| AVG Volume (30 Days) | ★ 2.3M | 926.0K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.95 | 73.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,939,000.00 | N/A |
| Revenue This Year | $3,454.98 | N/A |
| Revenue Next Year | $81.69 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 413.59 | N/A |
| 52 Week Low | $1.50 | $0.56 |
| 52 Week High | $6.40 | $4.99 |
Technical Indicators
Market Signals| Indicator | PROP | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 49.40 |
| Support Level | N/A | $2.02 |
| Resistance Level | $2.02 | $3.01 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 19.35 | 16.25 |
Price Performance
Historical ComparisonAbout PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.